Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Jeffrey Friedland currently holds 19,000,000 shares of Intiva BioPharma Inc. (KDRH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jeffrey Friedland has been a net seller of KDRH stock. They have purchased $0 and sold $450.0K worth of shares.
Jeffrey Friedland's most recent insider trade was on Nov 22, 2019, when they sold 228,800 shares at $0.00 per share.
Jeffrey Friedland serves as Executive at Intiva BioPharma Inc. (KDRH). They have executed 12 insider transactions totaling $450.0K over their tenure at the company.
Jeffrey Friedland holds the position of Executive at Intiva BioPharma Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 9 years and currently hold a stake valued at $0.
Jeffrey Friedland has shown a selling trading pattern, with $0 in total purchases and $450.0K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Jeffrey Friedland was on Apr 4, 2019, when they sold $450.0K worth of NXEN shares. This transaction involved 5,000,000 shares at $0.09 per share.
Jeffrey Friedland currently owns 19,000,000 shares of Intiva BioPharma Inc. (KDRH), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Jeffrey Friedland's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Jeffrey Friedland has 12 Form 4 filings on record as an insider at Intiva BioPharma Inc..
Set alerts for Jeffrey Friedland and 40,000+ other insiders.